Announced Mon, 29 Jun · 11:05 IST
Niraj Shah acquires 6.44% stake in Bacil Pharma via open market
Ownership Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹39.75
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-0.4+0.1+0.6+0.5-0.8-5.4-12.9———
Up moveDown movePending
AI summary
Niraj Rajnikant Shah, a non-promoter individual, acquired 9,25,000 equity shares (6.44%) of Bacil Pharma Ltd through open market purchases between June 22 and June 24, 2026. He held no shares in the company prior to this. The disclosure was filed under Regulation 29(1) of SEBI Takeover Regulations as his holding crossed the 5% disclosure threshold.
Likely market impact
A non-promoter individual has built a 6.44% stake via open market buys, crossing the 5% disclosure trigger. Watch for further buying approaching the 10% bracket.